BFA
TCRT icon

BlackRock Fund Advisors’s Alaunos Therapeutics TCRT Stock Holding History

BlackRock Fund Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$19.4M Buy
24,146
+3,591
+17% +$3.24M ﹤0.01% 2197
2016
Q3 		$17.4M Buy
20,555
+1,311
+7% +$1.05M ﹤0.01% 2147
2016
Q2 		$15.8M Buy
19,244
+734
+4% +$799K ﹤0.01% 2161
2016
Q1 		$20.6M Sell
18,510
-714
-4% -$731K ﹤0.01% 1977
2015
Q4 		$24M Buy
19,224
+1,071
+6% +$1.77M 0.01% 1925
2015
Q3 		$24.5M Sell
18,153
-115
-0.6% -$190K 0.01% 1860
2015
Q2 		$32.9M Buy
18,268
+1,250
+7% +$1.94M 0.01% 1795
2015
Q1 		$27.5M Buy
17,018
+1,858
+12% +$2.75M 0.01% 1888
2014
Q4 		$11.5M Buy
15,160
+2,044
+16% +$1.09M ﹤0.01% 2379
2014
Q3 		$5.19M Sell
13,116
-432
-3% -$208K ﹤0.01% 2733
2014
Q2 		$8.19M Sell
13,548
-1,463
-10% -$815K ﹤0.01% 2543
2014
Q1 		$10.3M Buy
15,011
+600
+4% +$402K ﹤0.01% 2387
2013
Q4 		$9.38M Buy
14,411
+1,812
+14% +$1.08M ﹤0.01% 2432
2013
Q3 		$7.45M Buy
12,599
+1,457
+13% +$657K ﹤0.01% 2545
2013
Q2 		$3.53M Buy
+11,142
New +$3.09M ﹤0.01% 2907

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock Fund Advisors's TCRT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Alaunos Therapeutics (TCRT) stake by 17% in Q4 2016, buying an estimated $3.24M and bringing the position to 24,146 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

BlackRock Fund Advisors first reported a position in TCRT in Q2 2013 and has held it in 15 quarters since. The position peaked at $32.9M in Q2 2015. 136 funds tracked by Wall St. Rank hold TCRT as of Q4 2016.

  • BlackRock Fund Advisors held 24,146 shares of Alaunos Therapeutics worth $19.4M as of Q4 2016.
  • BlackRock Fund Advisors bought 3,591 Alaunos Therapeutics shares in Q4 2016, an estimated $3.24M.
  • Alaunos Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2197 holding.
  • BlackRock Fund Advisors first reported a position in Alaunos Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Alaunos Therapeutics position peaked at $32.9M in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.